C P Pharmaceuticals world class workforce in line to produce Covid-19 vaccines
- Monday 3 August 2020
C P Pharmaceuticals, through its parent company Wockhardt, has entered into a contract with the UK government to produce millions of doses of Covid-19 vaccines. The agreement - which reserves capacity at the C P Pharmaceutical site in Wrexham - will kick in once a viable vaccine is identified. Unite represents hundreds of workers at the world class pharmaceutical site.
Dave Griffiths, Unite regional officer, commented: “Unite is extremely proud of our members at C P Pharmaceuticals which will hopefully in the near future be at the forefront of the fight against Covid-19. It is testament to the world class workforce at Wrexham that they have been chosen to mass produce vaccines once a viable one is identified. We of course hope that this production will start in the near future as it is only through a process of mass vaccination that our lives can return to normal. Once again it is union members that are at the forefront of the fight against this terrible disease."
For further information please contact Glyn Conolly on 07974 131771